hc1 Acquires Lab Expert Accumen to Expand Data-Driven Lab Insights

Together, hc1 and Accumen improve patient care while boosting health system bottom lines through data insights

INDIANAPOLIS and SCOTTSDALE, Ariz.--(BUSINESS WIRE)--hc1, the healthcare information technology leader in improving patient care and reducing costs through real-time lab data insights, today announced it has acquired Accumen, a best-in-class healthcare performance consulting company based in Scottsdale, Arizona. Terms of the acquisition were not disclosed. The acquisition positions hc1 as the only comprehensive solution for transforming diagnostic labs into strategic assets for health systems.

Together, hc1 and Accumen will accelerate healthcare progress by harnessing the power of lab data to generate insights that improve patient care, streamline operations, and reduce costs, all while achieving healthy growth to enhance financial performance.

“The merger between hc1 and Accumen jumpstarts progress for the healthcare industry by taking labs off the backburner and turning them into goldmines of data and financial growth for health systems,” said CEO of hc1, Bradley A. Bostic. “All health systems have a lab, and yet they are underused as a tool to improve patient health through data-driven insights. By integrating hc1’s advanced data management technology and AI-powered analytics—the hc1 Lab Insights Platform™—with Accumen’s lab expertise, we are addressing the massive demand from health systems to mine maximum value from lab data. After over a decade of perfecting our approach and technology, we are partnering with healthcare leaders who want to unlock the hidden value of lab data within their health systems. Ultimately, it’s about effectively diagnosing patients and generating healthy financial results. hc1 is expanding faster than ever because we deliver both benefits at scale with a turnkey, secure cloud solution. This is truly the force-multiplier health systems have been looking for.”

• A long history of innovation: founded in 2011, hc1 and Accumen are at the forefront of turning complex laboratory data into actionable insights.
• Transforming the lab for a deep bench of partners: The company works with health systems and labs serving 90 million patients and 450 hospitals, using the hc1 Lab Insights Platform, workflow automation, and services to maximize the lab's impact throughout the continuum of care.
• Creating efficiency without sacrificing impact: with the acquisition of Accumen, hc1 delivers results faster and sustains improvements across the supply chain, blood management, staffing, lab stewardship, outreach growth, and beyond—all while effectively avoiding resource constraints. Expert consultants make it easy for health systems to go live through a proven process that doesn’t strain IT resources or disrupt ongoing operations.

Register for hc1’s upcoming webinar (https://hubs.la/Q02TZpz30) to hear hc1’s CEO, Bradley Bostic, discuss the acquisition and the secrets to unlocking growth and patient insights hidden inside lab data.

About hc1 + Accumen

hc1 + Accumen, together, unlock the vast potential of actionable lab data to transform labs into a strategic asset. Health system executives often face challenges in improving patient care and financial performance. By partnering with hc1 + Accumen, health systems can gain profitable new growth and improve patient outcomes. Our solutions use advanced data management, analytics, and workflow automation powered by AI to uncover actionable insights and hidden risk signals, delivering innovation, operational and clinical excellence, and revenue growth across the entire care continuum. With over a decade of experience and thousands of health systems and labs leveraging our technology and consultative services to care for nearly 100 million patients, we provide the expertise needed to unlock the strategic value of your lab data, improving patient outcomes and boosting financial performance. Healthcare Progress Starts Here.™ With hc1 + Accumen.

Learn more about our proven approach at www.hc1.com and follow us on LinkedIn.